Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.
Department of Pathology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.
Front Oncol. 2014 Jun 2;4:130. doi: 10.3389/fonc.2014.00130. eCollection 2014.
Malignant pleural effusions occur in the setting of both solid and hematologic malignancies. Pleural effusion caused by leukemic infiltration is an unusual extramedullary manifestation of acute myeloid leukemia (AML) with fewer than 20 cases reported (1-11). We report a case of pericardial and pleural effusions in a patient with AML and review the literature.
In this case, a 55-year-old man with previous history of myeloproliferative neoplasm experienced transformation AML, heralded by appearance of leukemic pleural effusions. The patient was identified to have leukemic pleural effusion based on the extended cytogenetic analysis of the pleural fluid, as morphologic analysis alone was insufficient.
The patient was treated with hypomethylator-based and intensive chemotherapy strategies, both of which maintained resolution of the effusions in the remission setting.
Due to the rarity of diagnosis of leukemic pleural effusions, both cytogenetic and fluorescence in situ hybridization testing are recommended. Furthermore, systemic chemotherapy directed at the AML can lead to complete resolution of leukemic pleural effusions.
恶性胸腔积液可发生于实体瘤和血液系统恶性肿瘤。白血病浸润引起的胸腔积液是急性髓系白血病(AML)的一种罕见的骨髓外表现,仅有不到 20 例报告(1-11)。我们报告了一例 AML 患者合并心包和胸腔积液,并复习了文献。
本例患者为 55 岁男性,既往有骨髓增殖性肿瘤病史,发生 AML 转化,表现为白血病性胸腔积液。该患者通过胸腔积液的扩展细胞遗传学分析确定为白血病性胸腔积液,因为单纯形态学分析不够。
患者接受了基于低甲基化剂和强化化疗的治疗策略,两种策略都在缓解期维持了胸腔积液的消退。
由于白血病性胸腔积液的诊断罕见,建议进行细胞遗传学和荧光原位杂交检测。此外,针对 AML 的全身化疗可导致白血病性胸腔积液完全消退。